XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Basis of Presentation - Schedule of Corrections of Accounting (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Total current assets $ 628,778   $ 628,778   $ 3,860,967
Total assets 10,859,956   10,859,956   6,568,694
Derivative liabilities 2,477,340   2,477,340    
Notes payable 5,401,068   5,401,068    
Liquidated damages payable under registration rights agreements 15,001   15,001  
Other current liabilities 1,015,356   1,015,356    
Total liabilities 8,908,765   8,908,765   3,416,444
Redeemable Series G convertible preferred stock 168,496   168,496   168,496
Total stockholders' equity 1,782,695   1,782,695   2,983,754
Total liabilities and stockholders' equity 10,859,956   10,859,956   $ 6,568,694
Revenue 216,356 303,041  
Gross loss (886,457) (192,039) (1,835,480) (192,039)  
Total operating expenses 2,989,937 1,396,624 5,612,843 2,401,506  
Loss from operations (3,876,394) (1,588,663) (7,448,323) (2,593,545)  
Change in derivatives valuation 128,544        
Interest expense (123,543)   (123,543)    
Interest income 14,384 296 14,384 350  
True-up termination fee (1,344,648) (1,344,648)  
Liquidated damages under registration rights agreements (15,001) (15,001)  
Net loss $ (5,216,658) $ (1,588,367) $ (8,788,587) $ (2,593,195)  
Basic and diluted net loss per common share $ (0.21) $ (0.12) $ (0.36) $ (0.23)  
Common stock, shares outstanding 31,119,016   31,119,016   28,516,009
Common stock, par value $ 311,189   $ 311,189   $ 285,159
Additional paid-in capital 18,732,164   18,732,164   11,170,666
Accumulated deficit (17,260,658)   (17,260,658)   $ (8,472,071)
Net cash used in operating activities     (4,104,967) $ (1,738,072)  
Net cash used in investing activities     (7,157,631) (948,800)  
Net cash provided by financing activities     7,759,536 3,537,052  
Net decrease in cash and restricted cash     (3,503,062) 850,180  
Balance at beginning of period     3,619,249 598,294  
Balance at end of period 116,187 $ 1,448,474 116,187 $ 1,448,474  
Reported [Member]          
Total current assets 628,778   628,778    
Total assets 10,845,572   10,845,572    
Derivative liabilities 1,856,394   1,856,394    
Notes payable 2,895,103   2,895,103    
Liquidated damages payable under registration rights agreements      
Other current liabilities 1,460,227   1,460,227    
Total liabilities 6,211,724   6,211,724    
Redeemable Series G convertible preferred stock 168,496   168,496    
Total stockholders' equity 4,465,352   4,465,352    
Total liabilities and stockholders' equity 10,845,572   10,845,572    
Revenue 216,356   303,041    
Gross loss (867,966)   (1,816,989)    
Total operating expenses 2,729,691   5,352,597    
Loss from operations (3,597,657)   (7,169,586)    
Change in derivatives valuation 315,194   315,194    
Interest expense (179,155)   (179,155)    
Interest income      
True-up termination fee      
Liquidated damages under registration rights agreements      
Net loss $ (3,461,618)   $ (7,033,547)    
Basic and diluted net loss per common share $ (0.14)   $ (0.29)    
Common stock, shares outstanding 30,975,206   30,975,206    
Common stock, par value $ 309,751   $ 309,751    
Additional paid-in capital 19,661,219   19,661,219    
Accumulated deficit (15,505,618)   (15,505,618)    
Net cash used in operating activities     (4,104,967)    
Net cash used in investing activities     (7,157,631)    
Net cash provided by financing activities     7,759,536    
Net decrease in cash and restricted cash     (3,503,062)    
Balance at beginning of period     3,619,249    
Balance at end of period 116,187   116,187    
Adjustment [Member]          
Total current assets      
Total assets 14,384   14,384    
Derivative liabilities 620,946   620,946    
Notes payable 2,505,965   2,505,965    
Liquidated damages payable under registration rights agreements 15,001   15,001    
Other current liabilities (444,871)   (444,871)    
Total liabilities 2,697,041   2,697,041    
Redeemable Series G convertible preferred stock      
Total stockholders' equity (2,682,657)   (2,682,657)    
Total liabilities and stockholders' equity 14,384   14,384    
Revenue      
Gross loss (18,491)   (18,491)    
Total operating expenses 260,246   260,246    
Loss from operations (278,737)   (278,737)    
Change in derivatives valuation (186,650)   (186,650)    
Interest expense 55,612   55,612    
Interest income 14,384   14,384    
True-up termination fee (1,344,648)   (1,344,648)    
Liquidated damages under registration rights agreements (15,001)   (15,001)    
Net loss $ (1,755,040)   $ (1,755,040)    
Basic and diluted net loss per common share $ (0.07)   $ (0.08)    
Common stock, shares outstanding 143,810   143,810    
Common stock, par value $ 1,438   $ 1,438    
Additional paid-in capital (929,055)   (929,055)    
Accumulated deficit (1,755,040)   (1,755,040)    
Net cash used in operating activities        
Net cash used in investing activities        
Net cash provided by financing activities        
Net decrease in cash and restricted cash        
Balance at beginning of period        
Balance at end of period